To include your compound in the COVID-19 Resource Center, submit it here.

Omecamtiv mecarbil: Phase IIb started

Cytokinetics and partner Amgen began a double-blind, placebo-controlled, international Phase IIb trial

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE